Modeling Subject Recruitment in Medical and Clinical Investigations

Evaluation and monitoring of subject recruitment are important in medical research (Schroen et al., 2010). Delaying recruitment of subjects will increase the cost of the study and / or may result in researchers adapting to smaller sample sizes than originally suggested. If the recommended sample size has not been reached, the detection power of the test may decrease and the therapeutic effect may not be determined. Slow recruitment tends to increase the use of resources, including the contribution of goodwill of patient volunteers. The delay in recruitment may also delay adoption of new therapies and delaying the advancement of medical science (Philipson et al., 2010).

Human research is a systematic and scientific research which may be an intervention ("test") or observation ("no test article") and includes human beings as research subjects. Human studies are either medical (clinical) research or non-medical (social science) studies. A systematic survey involves collecting and analyzing data to answer specific questions. Medical human studies often include biological specimen analysis, epidemiological and behavioral studies, and chart review studies. (A specific, particularly highly regulated, medical human subject's research type is a "clinical trial" in which medicines, vaccines, and medical equipment are evaluated.) On the other hand, human subject research in social science, Usually survey questions are included for specific people. Survey methods include questionnaires, interviews and focus groups

Each clinical trial is based on data from basic or basic translation or other clinical trials. We are often suspected to be talking about clinical trials of drug therapy, but it may also be a procedure. Researchers involved in patient recruitment for clinical trials may or may not be the same researchers, but clinical trials are being conducted to examine patients ideal for this clinical trial and those undergoing clinical trials Study mandated There will be some confusion if patients with harmful characteristics or they participate in clinical trials

Pharmaceutical companies traditionally designed and implemented their own clinical trials. They chose the research site and recruited researchers to conduct testing of new drugs. Investigators are usually professors of medical departments in hospital education but are also specialized research centers or occasionally specialized researchers who conduct clinical trials at their private clinic, in particular Phase IV trial regular doctors. Later, these researchers recruited patients to participate in this study, sometimes with the help of pharmaceutical companies.